Specialized Disclosure Report (sd)
May 31 2016 - 4:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
AMGEN INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-37702
|
|
95-3540776
|
(State or other jurisdiction
of corporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
One Amgen Center Drive, Thousand Oaks, CA
|
|
91320-1799
|
(Address of principal executive offices)
|
|
(zip code)
|
Venkata Yepuri
Amgen Inc.
(805)
313-1449
(Name and telephone number, including area code, of the person to contact in connection with this report)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form
applies:
x
|
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2015.
|
Section 1Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
Conflict Minerals Disclosure
This Form SD is filed by
Amgen Inc. (the Company) pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934 for the reporting period January 1, 2015, to December 31, 2015.
A copy of the Companys Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD, and has been posted on Amgens external website at
http://www.amgen.com/conflictmineralsreport
. References in this Form SD to the Companys website are not intended to function as hyperlinks and the information contained on the Companys website is not intended to be part of this
Report.
Item 1.02 Exhibit
As specified in
Section 2, Item 2.01 of this Form SD, the Company is hereby filing its Conflict Minerals Report as Exhibit 1.01 to this report.
Section 2Exhibits
Item 2.01 Exhibits
The following exhibit is filed as part of this report.
|
|
|
Exhibit No
|
|
Description
|
|
|
1.01
|
|
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly
authorized undersigned.
|
|
|
|
|
|
|
|
|
|
|
AMGEN INC
.
|
|
|
|
|
Date: May 31, 2016
|
|
|
|
By:
|
|
/s/ David W. Meline
|
|
|
|
|
Name:
|
|
David W. Meline
|
|
|
|
|
Title:
|
|
Executive Vice President and Chief Financial Officer
|
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Apr 2023 to Apr 2024